Humanigen Inc reports results for the quarter ended in September - Earnings Summary

Humanigen

15/11/2022 03:25

* Humanigen Inc  HGEN.OQ  reported a quarterly adjusted loss
of 23
cents​​ per share for the quarter ended in September. The mean
expectation of four analysts for the quarter was for a loss
of 18 cents per share.
    * Revenue fell 78.7% to $221.00 thousand from a year ago;
analysts
expected $520.00 thousand. 
    * Humanigen Inc's reported EPS for the quarter was a loss
of 23
cents​.
    * The mean earnings estimate of analysts had risen by
about 7.7%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Humanigen Inc shares had fallen by 16.0% this quarter and
lost 95.9% so far this year.
    * The company reported a quarterly loss of $23.69 million.
    * Wall Street's median 12-month price target for Humanigen
Inc is
$2.00 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 3
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
15 at 03:25 a.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.18          -0.23          Missed
 Jun. 30 2022      -0.30          -0.43          Missed
 Mar. 31 2022      -0.46          -0.32          Beat
 Dec. 31 2021      -0.65          -0.53          Beat